Your browser doesn't support javascript.
loading
Survival benefit in patients with peripheral T-cell lymphomas after treatments with novel therapies and clinical trials.
Ma, Helen; Cheng, Bin; Falchi, Lorenzo; Marchi, Enrica; Sawas, Ahmed; Bhagat, Govind; O'Connor, Owen A.
Afiliación
  • Ma H; Division of Hematology and Oncology, New York Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York.
  • Cheng B; Department of Biostatistics, Columbia University Irving Medical Center, New York, New York.
  • Falchi L; Division of Hematology and Oncology, New York Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York.
  • Marchi E; Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, New York.
  • Sawas A; Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, New York.
  • Bhagat G; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York.
  • O'Connor OA; Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, New York.
Hematol Oncol ; 38(1): 51-58, 2020 Feb.
Article en En | MEDLINE | ID: mdl-31872891

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hematol Oncol Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hematol Oncol Año: 2020 Tipo del documento: Article